BTI
VIR icon

Blue Trust Inc’s Vir Biotechnology VIR Stock Holding History

Blue Trust Inc’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-3,989
Closed -$35.5K – 2990
2024
Q3 		$35.5K Buy
3,989
+2,351
+144% +$20.4K ﹤0.01% 1711
2024
Q2 		$16.6K Buy
1,638
+1,621
+9,535% +$15.5K ﹤0.01% 1744
2024
Q1 		$172 Buy
17
+2
+13% +$20 ﹤0.01% 2085
2023
Q4 		$0 Sell
15
-1,542
-99% -$14.1K ﹤0.01% 2705
2023
Q3 		$39K Buy
1,557
+522
+50% +$7.45K ﹤0.01% 934
2023
Q2 		$24K Sell
1,035
-4,565
-82% -$115K ﹤0.01% 991
2023
Q1 		$141K Buy
5,600
+4,937
+745% +$126K ﹤0.01% 657
2022
Q4 		$12K Buy
663
+653
+6,530% +$16K ﹤0.01% 1488
2022
Q3 		$0 Buy
+10
New +$254 ﹤0.01% 2341

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Blue Trust Inc's VIR Position: Q4 2024 in Review

Blue Trust Inc sold out of Vir Biotechnology (VIR) in Q4 2024, closing a stake of 3,989 shares — an estimated $35.5K sold.

Blue Trust Inc first reported a position in VIR in Q3 2022 and held it in 9 quarters. The position peaked at $141K in Q1 2023. 208 funds tracked by Wall St. Rank hold VIR as of Q4 2024.

  • Blue Trust Inc reported no remaining Vir Biotechnology position as of Q4 2024 after selling out during the quarter.
  • Blue Trust Inc sold 3,989 Vir Biotechnology shares in Q4 2024, an estimated $35.5K.
  • Blue Trust Inc first reported a position in Vir Biotechnology in Q3 2022 and held it in 9 quarters.
  • Blue Trust Inc's Vir Biotechnology position peaked at $141K in Q1 2023.
  • 208 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2024.

Based on Blue Trust Inc's 13F filing for Q4 2024, filed 22 Jan 2025.